Alopecia areata continues to be a challenging condition to treat for many patients. Recently, there have been some significant developments with potentially dramatic impact in helping patients with the most severe cases of alopecia areata. Both involve oral medications that affect the immune system and therefore have potential side effects associated with them. Currently, there are clinical trials underway to see whether or not topical treatments can be as effective with less potential side effects. We hope to see positive results in the near future.
You Might Also Enjoy...
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
Interesting article regarding study showing no surgery scars in mice.
Interesting study giving us more information regarding the possible cause of alopecia areata.
The study published in the Lancet in January 2021 regarding long term clinical effects of recovered COVID-19 patients confirms what we have seen in our office over the past several months - increased rates of hair loss.
A recent study shows an association between finasteride use and psychological adverse events.
We have seen a vast increase in hair loss patients who have suffered from COVID.
